Impaired chemoreflex responses are a central feature of opioid-induced respiratory depression, however, the mechanism through which mu opioid receptor agonists lead to diminished chemoreflexes is not fully understood. The gene discussed is OPRM1; the disease is Respiratory insufficiency due to muscle weakness.